Title : ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells.

Pub. Date : 2010 Apr 15

PMID : 20139705






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. vandetanib AKT serine/threonine kinase 1 Homo sapiens
2 ZD6474 inhibited cell proliferation in a dose-dependent manner, by blocking cell progression at the G(0)-G(1) stage, through downregulation of expression of cyclin D1 and cyclin E. In vitro, ZD6474 inhibited growth factor-induced phosphorylation of EGFR, VEGFR-2, MAPK and Akt. vandetanib AKT serine/threonine kinase 1 Homo sapiens